DOVER, Del. (AP) — A federal judge in Delaware has refused to issue a restraining order delaying the acquisition of Human Genome Sciences Inc. by GlaxoSmithKline.

Two HGS shareholders had argued that the tender offer period should be extended beyond Friday’s deadline because Glaxo’s agreement last week to pay $14.25 a share represented a new deal compared to its unsolicited April offer of $13 per share.

Recommended Stories

French protest violence eases and scattered riots hit Germany ahead of more action

Somali pirates seize Iranian fishing vessel, raising fears of attacks on cargo ships

Four reasons why Democrats deserve a midterm shock